GSK Bringing $2.6B Takeover Bid To Human Genome Investors – site.law360.com
Law360, New York (May 09, 2012, 4:39 PM ET) -- GlaxoSmithKline PLC will sidestep a requested review from takeover target Human Genome Science Inc. and instead put its unsolicited $2.59 billion bid directly up to a Human Genome shareholder vote, GSK said ...
Subscribe to LegalLaw247.Com Newsletter